|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 16/00 | (2006.01) |
| C07K 16/30 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61P 31/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 37/00 | (2006.01) |
| (11) | Number of the document | 1945665 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06846120.1 |
| Date of filing the European patent application | 2006-10-20 | |
| (97) | Date of publication of the European application | 2008-07-23 |
| (45) | Date of publication and mention of the grant of the patent | 2011-12-07 |
| (46) | Date of publication of the claims translation | 2012-01-25 |
| (86) | Number | PCT/US2006/060113 |
| Date | 2006-10-20 |
| (87) | Number | WO 2007/048122 |
| Date | 2007-04-26 |
| (30) | Number | Date | Country code |
| 728947 P | 2005-10-21 | US |
| (72) |
MCPHERSON, John, M., US
EDMUNDS, Tim, US
ZHOU, Qun, US
|
| (73) |
GENZYME CORPORATION,
500 Kendall Street, Cambridge, MA 02142,
US
|
| (74) |
Vytautas GUOBYS,
Ateities g. 3-9, LT-08306 Vilnius,
LT
|
| (54) | Terapijos priemonė antikūnų pagrindu su padidintu ADCC aktyvumu |
| ANTIBODY-BASED THERAPEUTICS WITH ENHANCED ADCC ACTIVITY |
| Payment date | Validity (years) | Amount | |
| 2018-09-13 | 13 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2019-10-20 |